BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32061932)

  • 21. Blood-Brain Barrier Permeable Chitosan Oligosaccharides Interfere with β-Amyloid Aggregation and Alleviate β-Amyloid Protein Mediated Neurotoxicity and Neuroinflammation in a Dose- and Degree of Polymerization-Dependent Manner.
    Zhu L; Li R; Jiao S; Wei J; Yan Y; Wang ZA; Li J; Du Y
    Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 32992800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
    J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine Regulates β-Sheet Structure Formation in Amyloid-β
    Coskuner O; Uversky VN
    J Chem Inf Model; 2017 Jun; 57(6):1342-1358. PubMed ID: 28474890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils.
    Ahmed M; Davis J; Aucoin D; Sato T; Ahuja S; Aimoto S; Elliott JI; Van Nostrand WE; Smith SO
    Nat Struct Mol Biol; 2010 May; 17(5):561-7. PubMed ID: 20383142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42.
    Chemuru S; Kodali R; Wetzel R
    J Mol Biol; 2016 Jan; 428(2 Pt A):274-291. PubMed ID: 26122432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer's amyloid-β peptide.
    Madhu P; Das D; Mukhopadhyay S
    Phys Chem Chem Phys; 2021 Apr; 23(16):9686-9694. PubMed ID: 33908427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of Inter-Molecular Interactions Between Single Aβ
    Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
    J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brazilin inhibits the Zn
    Guo J; Sun W; Liu F
    J Inorg Biochem; 2017 Dec; 177():183-189. PubMed ID: 28972932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils.
    Bieschke J; Herbst M; Wiglenda T; Friedrich RP; Boeddrich A; Schiele F; Kleckers D; Lopez del Amo JM; Grüning BA; Wang Q; Schmidt MR; Lurz R; Anwyl R; Schnoegl S; Fändrich M; Frank RF; Reif B; Günther S; Walsh DM; Wanker EE
    Nat Chem Biol; 2011 Nov; 8(1):93-101. PubMed ID: 22101602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity?
    Saraiva AM; Pereira MC; Brezesinski G
    Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species.
    Jan A; Adolfsson O; Allaman I; Buccarello AL; Magistretti PJ; Pfeifer A; Muhs A; Lashuel HA
    J Biol Chem; 2011 Mar; 286(10):8585-8596. PubMed ID: 21156804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectroscopic Signature for Stable β-Amyloid Fibrils versus β-Sheet-Rich Oligomers.
    Lomont JP; Rich KL; Maj M; Ho JJ; Ostrander JS; Zanni MT
    J Phys Chem B; 2018 Jan; 122(1):144-153. PubMed ID: 29220175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctionality of Acidulated Serum Albumin on Inhibiting Zn²⁺-Mediated Amyloid β-Protein Fibrillogenesis and Cytotoxicity.
    Xie B; Dong X; Wang Y; Sun Y
    Langmuir; 2015 Jul; 31(26):7374-80. PubMed ID: 26070334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β
    Shuaib S; Narang SS; Goyal D; Goyal B
    J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.